Home Tags Xolair® (omalizumab)

Study: Anti-IgE Shots During Pregnancy May Provide a Lifetime of Protection...

Dave Bloom - 2018/12/17 0

FDA Grants Xolair Breakthrough Therapy Designation for Food Allergies

News Wire ~ 3rd Party Press Release - 2018/08/13 0

Study: Drug Increases Speed and Safety of OIT for Multiple Allergies

Dave Bloom - 2017/12/12 0

Study: New Gene Therapy Protects Against Anaphylaxis from Peanut Allergy

Dave Bloom - 2016/07/14 1

1 23Page 3 of 3

Put Your School on the Map

Dave Bloom - 2024/07/31 0

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: Xolair® (omalizumab)

Study: Anti-IgE Shots During Pregnancy May Provide a Lifetime of Protection...

FDA Grants Xolair Breakthrough Therapy Designation for Food Allergies

Study: Drug Increases Speed and Safety of OIT for Multiple Allergies

Study: New Gene Therapy Protects Against Anaphylaxis from Peanut Allergy

Follow Us

Your School On Our Map

Put Your School on the Map